Track Lucira Health, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Lucira Health, Inc. LHDX · Stock Open Lucira Health, Inc. in new tab

0.4523 USD
Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Lucira Health, Inc. (LHDX)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Lucira Health, Inc. Logo Lucira Health, Inc. Analysis (LHDX)

United States Health Care Official Website Stock

Is Lucira Health, Inc. a good investment? Lucira Health, Inc. (LHDX) is currently trading at 0.4523 USD.

Investor FAQ

Does Lucira Health, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Lucira Health, Inc.?

Lucira Health, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.

Exchange Ticker
NMS (United States) LHDX
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion